Naturally acquired antibodies to Plasmodium vivax Duffy binding protein (DBP) in Brazilian Amazon.

The American Journal of Tropical Medicine and Hygiene
F A Souza-SilvaLuzia H Carvalho

Abstract

Duffy binding protein (DBP), a leading malaria vaccine candidate, plays a critical role in Plasmodium vivax erythrocyte invasion. Sixty-eight of 366 (18.6%) subjects had IgG anti-DBP antibodies by enzyme-linked immunosorbent assay (ELISA) in a community-based cross-sectional survey in the Brazilian Amazon Basin. Despite continuous exposure to low-level malaria transmission, the overall seroprevalence decreased to 9.0% when the population was reexamined 12 months later. Antibodies from 16 of 50 (36.0%) subjects who were ELISA-positive at the baseline were able to inhibit erythrocyte binding to at least one of two DBP variants tested. Most (13 of 16) of these subjects still had inhibitory antibodies when reevaluated 12 months later. Cumulative exposure to malaria was the strongest predictor of DBP seropositivity identified by multiple logistic regression models in this population. The poor antibody recognition of DBP elicited by natural exposure to P. vivax in Amazonian populations represents a challenge to be addressed by vaccine development strategies.

References

Aug 5, 1976·The New England Journal of Medicine·L H MillerM H McGinniss
Jan 1, 1991·Molecular and Biochemical Parasitology·X D FangL H Miller
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·A Ranjan, C E Chitnis
Nov 7, 2000·Revista Da Sociedade Brasileira De Medicina Tropical·M T CavasiniM U Ferreira
Mar 21, 2002·Tropical Medicine & International Health : TM & IH·T T WinF Kawamoto
Mar 8, 2003·Revista Da Sociedade Brasileira De Medicina Tropical·Ellen K SilbergeldRui S U da Silva
Apr 22, 2003·Infection and Immunity·Jia XainliChristopher L King
Jun 3, 2004·The Lancet Infectious Diseases·Simon I HayRobert W Snow
Oct 23, 2004·Proceedings of the National Academy of Sciences of the United States of America·Kelley M VanBuskirkJohn H Adams
Feb 25, 2006·Cell·Alan F Cowman, Brendan S Crabb
May 2, 2006·Advances in Parasitology·C A GuerraS I Hay
Jun 6, 2006·Cadernos de saúde pública·Mônica da Silva-NunesMarcelo Urbano Ferreira
Aug 1, 2006·Trends in Biochemical Sciences·Amy M McHenry, John H Adams
May 19, 2007·Clinical Chemistry·Julian C GrayAndrea Crisanti
Aug 19, 2007·Clinical and Vaccine Immunology : CVI·Melissa S BastosMarcelo U Ferreira
Oct 16, 2007·Trends in Parasitology·J Kevin Baird
Nov 21, 2007·Trends in Parasitology·Chetan E Chitnis, Amit Sharma
Dec 25, 2007·Cadernos de saúde pública·Alisson Flávio Barbieri, Diana Oya Sawyer
Jun 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Christopher L KingChetan E Chitnis
Jun 20, 2008·Nature Immunology·Jean LanghorneKevin Marsh

❮ Previous
Next ❯

Citations

Feb 3, 2016·FEMS Microbiology Reviews·James G BeesonJack S Richards
Oct 22, 2009·International Journal of Health Geographics·Martin KulldorffKevin Konty
Jan 5, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Vahideh ValizadehNavid Dinparast Djadid
Sep 4, 2014·Memórias do Instituto Oswaldo Cruz·Taís Nóbrega de SousaLuzia Helena Carvalho
Sep 9, 2011·Memórias do Instituto Oswaldo Cruz·Sócrates Herrera ValenciaMyriam Arévalo-Herrera
Dec 3, 2016·International Journal for Parasitology·Wai-Hong ThamJulian C Rayner
Oct 24, 2019·Immunological Reviews·Lis R AntonelliRicardo T Gazzinelli
Jul 27, 2010·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·D SmolarekA G de Brevern

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.